Sitagliptin-induced pancreatitis - a longer road than expected
Related Experiment Video
Updated: Apr 21, 2026

A Simple and Rapid Method for Simultaneous Isolation of Primary Islets and Primary Pancreatic Acinar Cells from Mice
Published on: January 9, 2026
Matthew Nelson1, Niyati Bhandari2, Jill Wener3
1Department of Internal Medicine- Rush University Medical Center, Roosevelt University College of Pharmacy 1400 N Roosevelt Blvd, Schaumburg, Illinois, 60173.
Key Clinical Message:
Sitagliptin-induced pancreatitis can occur at any time after the initiation of therapy, even after several years. Patients taking sitagliptin who present with signs and symptoms of mild or severe pancreatitis should immediately discontinue sitagliptin and use an alternate medication regimen for control of type 2 diabetes.
Related Concept Videos
Dipeptidyl Peptidase 4 Inhibitors
Oral Hypoglycemic Agents: Glinides
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Acute Pancreatitis II: Clinical Manifestations and Management
Oral Hypoglycemic Agents: Biguanides and Glitazones
Acute Pancreatitis II: Pathophysiology

